UnitedHealth Group (UNH) Q1 2026 earnings review
Margin Over Membership: The Turnaround Playbook is Working
UnitedHealth Group executed exactly what it promised in late 2025: a ruthless pruning of unprofitable membership to rescue its collapsing margins. Total revenues grew a decelerating 2% YoY to $111.7B, but the real story is profitability. The Medical Care Ratio (MCR) plummeted to 83.9% from the disastrous near-90% levels seen in mid-2025, and UnitedHealthcare's operating margin expanded to 6.6%. The cost of this recovery was steep but intentional: shedding 965,000 Medicare Advantage seniors and 220,000 Medicaid members. With Q1 adjusted EPS of $7.23, management confidently raised FY26 adjusted EPS guidance to greater than $18.25. The core business is stabilizing, though elevated operating costs from heavy tech and restructuring investments demand monitoring.
🐂 Bull Case
The company successfully forced through aggressive repricing actions across Medicare and Commercial books. The MCR drop to 83.9% proves UNH can quickly realign premiums with the persistently elevated medical cost trends.
Despite losing significant volume from UHC, Optum generated $3.3B in earnings. Adjusting out the Q4 loss contract reserves, Optum Health's margin reached a healthy 5.4%, indicating the 'back to basics' value-based care restructuring is gaining traction.
🐻 Bear Case
Optum Health revenues fell 3% YoY and Optum Rx adjusted scripts dropped by 25 million. As UHC sheds millions of lives, the downstream volume loss at Optum limits enterprise revenue growth.
The Operating Cost Ratio jumped 140 bps YoY to 13.8%. While framed as strategic investments in AI and modernization, this significantly offsets the hard-fought gains in medical cost management.
⚖️ Verdict: 🟢
Bullish. The 2025 margin collapse was the existential threat to UNH. The Q1 results confirm they have successfully reversed the MCR deterioration. The membership losses were highly telegraphed and represent a necessary excision of unprofitable risk.
Key Themes
Aggressive Repricing Restores UHC Margins
Reversing the catastrophic trends of 2025, UnitedHealthcare's operating margin rebounded to 6.6% (up from 6.2% YoY and substantially up from the sub-3% levels of 25H2). This was driven by disciplined repricing across all lines of business. Management explicitly accepted top-line stagnation to ensure premiums actually covered the elevated utilization and unit cost trends that continue to plague the industry.
The Downstream Casualties of Membership Cuts
The deliberate shedding of 965k Medicare Advantage and 220k Medicaid members successfully repaired UHC's margins, but it is starving Optum of volume. Optum Health revenue decelerated to a 3% YoY decline ($24.1B) due to fewer value-based care members. Furthermore, Optum Rx adjusted scripts collapsed from 408M in 25Q1 to 383M in 26Q1, directly citing 'UHC membership attrition' as the cause. UNH must prove Optum can win enough external business to replace the captive UHC volume.
Operating Cost Ratio Spikes on Modernization Spend
The operating cost ratio deteriorated sharply, rising from 12.4% in 25Q1 to 13.8% in 26Q1. Management attributed this to 'incremental investments in people, processes and technology, including artificial intelligence.' While accelerating simplification and cybersecurity is necessary post-Change Healthcare, investors should watch closely to ensure these AI investments eventually yield the promised efficiency gains rather than becoming permanent structural bloat.
Massive Corporate and Portfolio Overhaul
UNH is executing a sweeping corporate reset. They refreshed nearly 50% of the top 100 leadership roles, exited non-U.S. businesses (completing the Optum UK sale and committing $400M in proceeds to the United Health Foundation), and created a new Public Responsibility Committee of the Board. This represents a concerted effort to clean up the operational and PR failures of the past two years.
Strategic Pivot in Consumer Accounts via Alegeus
In a notable strategic move, UNH agreed to acquire Alegeus Technologies, a benefits administration platform for consumer-directed healthcare accounts. This signals a pivot toward flexible, consumer-centered solutions, likely integrating closely with Optum Financial (now housed under Optum Insight). The deal is expected to close in H2 2026 and be earnings neutral for the year.
Other KPIs
Stable and highly robust. Operating cash flow represented 1.4x net income, demonstrating excellent earnings quality. Days claims payable increased sequentially to 48.6 (from 44.1 in 25Q4), which benefited working capital, though management noted this was driven by seasonality and claims payment timing.
Accelerating improvement toward the company's long-term target. The ratio dropped from 44.6% a year ago and 43.9% in 25Q4. Management expects to hit their ~40.0% target in the back half of 2026, which has allowed them to authorize at least $2.0B in share repurchases by the end of 26Q2.
Decelerating from 23.2% a year ago, primarily due to the absorption and realignment of Optum Financial into this segment, as well as continued investments in technology and new products. However, revenues grew slightly YoY to $5.1B.
Guidance
Accelerating. The company raised its full-year adjusted EPS guidance from the >$17.75 level indicated during the Q4 2025 call. This confirms management's confidence that the brutal repricing and membership cuts implemented in Q1 are successfully flowing through to the bottom line.
Accelerating. Raised from previous >$17.10 guidance, reflecting strong Q1 execution and the successful disposition of non-core assets like Optum UK.
Key Questions
Operating Cost Trajectory
The Operating Cost Ratio jumped 140 bps YoY to 13.8%. How much of this is related to one-time restructuring/leadership changes versus permanent structural investments in AI and cybersecurity? When should we expect AI investments to start bending this ratio back down?
Optum Health Volume Floor
With Optum Health revenues down 3% YoY due to fewer value-based care members, where is the floor for this segment's top-line? Is external payer growth sufficient to offset the intentional shedding of UHC lives throughout the remainder of 2026?
Alegeus Integration Strategy
How does the pending acquisition of Alegeus Technologies integrate with the recent realignment of Optum Financial into Optum Insight? Will this primarily serve UHC members, or is the goal to aggressively market this tech platform to external payers and employers?